{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:04:31Z","timestamp":1777352671900,"version":"3.51.4"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.1002\/ejhf.3141","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T01:29:50Z","timestamp":1705627790000},"page":"195-198","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reassessing the Management of Hypertension: Time to Prevent Aldosterone-Mediated Heart Failure"],"prefix":"10.1093","volume":"26","author":[{"given":"Bertram","family":"Pitt","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Michigan School of Medicine , Ann Arbor, MI ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenifer M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Diez","sequence":"additional","affiliation":[{"name":"Center for Applied Medical Research (CIMA), and School of Medicine, University of Navarra , Pamplona ,","place":["Spain"]},{"name":"Center for Network Biomedical Research of Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"2026010913040814100_ejhf3141-bib-0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/HYPERTENSIONAHA.122.19373","article-title":"Growing heart failure burden of hypertensive heart disease: A call to action","volume":"80","author":"Diez","year":"2023","journal-title":"Hypertension"},{"key":"2026010913040814100_ejhf3141-bib-0002","volume-title":"Global report on hypertension: The race against a silent killer","author":"World Health Organization","year":"2023"},{"key":"2026010913040814100_ejhf3141-bib-0003","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ejhf.2811","article-title":"Time to reconsider the perception and management of hypertensive heart disease","volume":"25","author":"D\u00edez","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026010913040814100_ejhf3141-bib-0004","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.mayocp.2018.05.027","article-title":"Aldosterone, hypertension, and antihypertensive therapy: Insights from a general population","volume":"93","author":"Cannone","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"2026010913040814100_ejhf3141-bib-0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020546","article-title":"The low-renin hypertension phenotype: Genetics and the role of the mineralocorticoid receptor","volume":"19","author":"Baudrand","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026010913040814100_ejhf3141-bib-0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: A cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026010913040814100_ejhf3141-bib-0007","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: A cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026010913040814100_ejhf3141-bib-0008","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.120.15006","article-title":"Serum aldosterone concentration, blood pressure, and coronary artery calcium: The Multhi-Ethnic Study of Atherosclerosis","volume":"76","author":"Inoue","year":"2020","journal-title":"Hypertension"},{"key":"2026010913040814100_ejhf3141-bib-0009","doi-asserted-by":"crossref","first-page":"F325","DOI":"10.1152\/ajprenal.00415.2020","article-title":"Aldosterone sensitivity: An opportunity to explore the pathogenesis of hypertension","volume":"320","author":"Gray","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026010913040814100_ejhf3141-bib-0010","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/HYPERTENSIONAHA.122.19134","article-title":"Cardiac structure and function across the spectrum of aldosteronism: The Atherosclerosis Risk in Communities study","volume":"79","author":"Brown","year":"2022","journal-title":"Hypertension"},{"key":"2026010913040814100_ejhf3141-bib-0011","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1111\/bph.15708","article-title":"Mineralocorticoid receptor in cardiovascular diseases \u2013 Clinical trials and mechanistic insights","volume":"179","author":"Bauersachs","year":"2022","journal-title":"Br J Pharmacol"},{"key":"2026010913040814100_ejhf3141-bib-0012","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2026010913040814100_ejhf3141-bib-0013","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: The PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026010913040814100_ejhf3141-bib-0014","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/HJH.0000000000003330","article-title":"Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes","volume":"41","author":"Agarwal","year":"2023","journal-title":"J Hypertens"},{"key":"2026010913040814100_ejhf3141-bib-0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N Engl J Med"},{"key":"2026010913040814100_ejhf3141-bib-0016","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.2023.16029","article-title":"Aldosterone synthase inhibition with lorundrostat for uncontrolled hypertension: The Target-HTN randomized clinical trial","volume":"330","author":"Laffin","year":"2023","journal-title":"JAMA"},{"key":"2026010913040814100_ejhf3141-bib-0017","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jchf.2019.09.011","article-title":"Mineralocorticoid receptor antagonists, blood pressure, and outcomes in heart failure with reduced ejection fraction","volume":"8","author":"Serenelli","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026010913040814100_ejhf3141-bib-0018","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ejhf.1060","article-title":"Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: An analysis of the TOPCAT trial","volume":"20","author":"Selvaraj","year":"2018","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/2\/195\/65513733\/eurjhf_26_2_195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/26\/2\/195\/65513733\/eurjhf_26_2_195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:04:45Z","timestamp":1767981885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/26\/2\/195\/8326951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,18]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3141","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"2023-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}